Fundraising FoxBrain Trust Accelerator Fund
Impact investorBurlingame · Seed–Series A · 1 people tracked
Find your way into Brain Trust Accelerator Fund
Each arrow is one introduction. Sign up to fill in the first one.
Ask Ryan Kraus to introduce you to John M. Reher
You →Ryan · together at Orange Digital Ventures →John
Sign up to find every way you can get introduced to Brain Trust Accelerator Fund
- Your email: who you already know at Brain Trust Accelerator Fund, and who your contacts know
- 2nd- and 3rd-degree connections: people you know who worked, studied or invested with the Brain Trust Accelerator Fund team
- Your LinkedIn: the connections who can make the intro for you
We rank every route by how warm it is, so you raise on warm intros instead of cold emails.
Investment thesis
The Brain Trust Accelerator Family of Funds invests in translational-stage opportunities aimed at improving the diagnosis and treatment of brain-related diseases, framing its work as impact investing in brain disease. The firm reports that its first fund generated top-tier returns, supported approaches with the potential to benefit up to ten million patients with brain diseases, and directed $500,000 to charities. It expresses similar optimism about the prospects for its second fund.
Source: firm website, verified Sep 27, 2026.
Team · 1 people
from public directoriesWhat they invest in
from 3 of 3 portfolio companiesBiotech ×2Healthtech ×2AI & Machine Learning ×1Digital Health ×1Medical Devices ×1
HQs:United States×3
Investments · 3 tracked
founders shown can be your intro pathBy year:2016 · 12010 · 12 dated
NeuroTherapia is a clinical-stage biotech company developing novel treatments for neuroinflammatory disorders, including Alzheimer's disease, neuropathic pain, multiple sclerosis, and ALS.
AI & Machine LearningBiotechDigital HealthHealthtechMedical DevicesCleveland, US
Co-investorsDolby Family Ventures
Irvine, CA based Alzheimer's drug company
BiotechWashington, US
Thomas N. Chase(Executive Officer, Director)Douglas Ingram(Executive Officer, Director)John M. Siebert(Executive Officer, Director)Kathleen Clarence-Smith(Executive Officer)
BoardNayan Greg Parekh(Director)
Board seatJohn M. Reher· per SEC Form D · $612.5K raise · filed Feb 2016
Co-investorsAndera PartnersNew Rhein Healthcare Investors, LLC
Other
Tracked investments with no reachable website or further public details — typically companies that wound down, renamed, or were absorbed.
Rows marked “SEC filing” are inferred from directors named on the company's SEC Form D — public regulatory data, not a portfolio list published by the firm.
Frequently asked questions
- What stage does Brain Trust Accelerator Fund invest at?
- Brain Trust Accelerator Fund invests at the Seed, Series A stages.
- What sectors does Brain Trust Accelerator Fund focus on?
- Brain Trust Accelerator Fund focuses on Biotech, Digital Health, Healthtech, Impact & Social Good, Medical Devices.
- Where is Brain Trust Accelerator Fund located?
- Brain Trust Accelerator Fund is headquartered in Burlingame, US.
Similar investors
Lerer Hippeau is an early-stage venture capital firm that backs founders across sectors, emphasizing investing in companies before they gain wider recognition.
Cancer Fund is an early-stage oncology venture capital and venture-giving organization that funds diagnostics, therapeutics, and other cancer-targeting innovations, offering both charitable donation and accredited-investor pathways.
Global Health Investment Corporation (GHIC) is a nonprofit that invests in life sciences and healthcare technology companies to accelerate the development and accessibility of products improving global public health and health equity.
Novo Holdings is the holding and investment company that manages the assets of the Novo Nordisk Foundation, serving as controlling shareholder of Novo Nordisk and Novonesis. It invests in life science companies across all stages and manages a diversified portfolio of equities, bonds, real estate, infrastructure and private equity.
MDI Ventures is the corporate venture capital arm of Indonesian telecommunications company Telkom Indonesia, investing in high-growth technology startups across Southeast Asia and globally, with a focus on creating synergies between portfolio companies and Telkom Group and Indonesian state-owned enterprises.